Literature DB >> 8883711

Early massive accumulation of In-111 pentetreotide in a metastatic liver tumor of islet cell carcinoma.

E Tsukamoto1, K Kanegae, K Itoh, S Okushiba, K Ohno, H Katoh, N Tamaki.   

Abstract

A 62-year-old woman was examined with In-111 pentetreotide and Ga-67 citrate. She had undergone an operation to resect a neuroendocrine tumor of the pancreas and still had masses in the liver. One of her hepatic lesions had been biopsied and acinar cell carcinoma was suspected. Fluid in the cyst of the tumor, however, contained a high concentration of gastrin and the tumor was strongly suspected of being a metastasis from the neuroendocrine tumor of the pancreas. The hepatic tumors quickly accumulated In-111 pentetreotide immediately after the injection, but there was no Ga-67 citrate uptake in the tumor. Five months after pentetreotide scintigraphy, her hepatic tumors were resected and histologically proven to be metastasis of islet cell carcinoma. In-111 pentetreotide provides information of the somatostatin-receptor status on the tumor and supports the diagnosis made by hormonal survey.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883711     DOI: 10.1007/bf03164742

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  17 in total

Review 1.  111In-octreotide scintigraphy in oncology.

Authors:  E P Krenning; D J Kwekkeboom; J C Reubi; P M Van Hagen; C H van Eijck; H Y Oei; S W Lamberts
Journal:  Metabolism       Date:  1992-09       Impact factor: 8.694

Review 2.  The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Authors:  S W Lamberts; E P Krenning; J C Reubi
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

3.  Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.

Authors:  J E Westlin; E T Janson; H Arnberg; H Ahlström; K Oberg; S Nilsson
Journal:  Acta Oncol       Date:  1993       Impact factor: 4.089

4.  In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue.

Authors:  J C Reubi; B Waser; U Horisberger; E Krenning; S W Lamberts; J O Gebbers; P Gersbach; J A Laissue
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

Review 5.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

6.  Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.

Authors:  K Joseph; J Stapp; J Reinecke; H J Skamel; H Höffken; C Neuhaus; H Lenze; M E Trautmann; R Arnold
Journal:  Horm Metab Res Suppl       Date:  1993

7.  In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.

Authors:  W H Bakker; E P Krenning; J C Reubi; W A Breeman; B Setyono-Han; M de Jong; P P Kooij; C Bruns; P M van Hagen; P Marbach
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

8.  Scintiscans and carcinoid tumors.

Authors:  B Carnaille; M Nocaudie; F Pattou; D Huglo; M Deveaux; X Marchandise; C Proye
Journal:  Surgery       Date:  1994-12       Impact factor: 3.982

9.  Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.

Authors:  F Tenenbaum; J Lumbroso; M Schlumberger; A Mure; P F Plouin; B Caillou; C Parmentier
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057

10.  Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.

Authors:  H Scherübl; M Bäder; U Fett; B Hamm; H Schmidt-Gayk; K Koppenhagen; F J Dop; E O Riecken; B Wiedenmann
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.